COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Research report issued by Quirin Privatbank Kapitalmarktgeschäft on Delticom AG, updating the recommendation to BUY with a target price of 3.80, expecting strong Q4 results and increased revenue forecast for 2025 -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: voestalpine AG: The Management Board of voestalpine AG resolves to use treasury shares to satisfy the subscription rights of the 2023 convertible bonds (if applicable)
voestalpine AG Management Board resolves to use treasury shares to satisfy 2023 convertible bonds subscription rights. Details on share buyback program and disclosure obligations -
COMMUNIQUÉ DE PRESSE
Medit recognized as the top brand in a global brand perception study by an external insights agency
Medit recognized as the top brand in a global brand perception study by an external insights agency. Medit achieves highest overall brand perception score and positive sentiment rate among intraoral scanner brands analyzed -
COMMUNIQUÉ DE PRESSE
Orqa Scales Production Capacity to 280,000 Drones, Eliminating Reliance on Chinese Drone Technology
Orqa scales production capacity to 280,000 drones at its headquarters in Croatia, eliminating reliance on Chinese technology. The expansion meets growing demand for secure, defence-grade UAS systems -
COMMUNIQUÉ DE PRESSE
BioNxt Signs Letter Agreement to Acquire 100% Interest in IP and to Codevelop a Sublingual Drug Formulation for Chemotherapy and Immunosuppressant Treatments
BioNxt Solutions collaborates with European chemotherapy company for novel sublingual drug formulation with high-potency ingredient. Focus on oncology and immunosuppressant treatments. Company plans to expand IP portfolio -
-
